Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS Rating: 5.03, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.03 new
Vol. 1, Issue 12 (2013)

Immunosuppressants: A Review

Author(s):
Permender Rathee, Hema Chaudhary, Sushila Rathee, Dharmender Rathee, Vikash Kumar
Abstract:
Advances in immunosuppressants over the past decade have resulted in dramatic improvements in short and long-term outcomes in organ transplantation as well as a decreased incidence of acute rejection. However, immunosuppressive drugs need to be given long term, lack specificity, and are accompanied by adverse metabolic derangements, toxicities, the risk of infection and cancer, and a myriad of other side effects. Further, they fail to prevent and control chronic rejection. This review will outline a number of immunosuppressive agents that are currently being explored in experimental and clinical transplantation. These include biologic agents that have more specificity and selectivity, and are aimed at T-cell depletion, blockade of costimulation, adhesion markers, or at novel targets.
Pages: 90-101  |  566 Views  22 Downloads
How to cite this article:
Permender Rathee, Hema Chaudhary, Sushila Rathee, Dharmender Rathee, Vikash Kumar. Immunosuppressants: A Review. 2013; 1(12): 90-101.
Journals List Click Here Research Journals Research Journals
Call for book chapter